Lv41
478 积分 2024-10-29 加入
Development of Small Molecular Hyper‐activators of Human Caseinolytic Peptidase P (hClpP) with a [1,8]‐Naphthyridinone Scaffold as Novel Anti‐cancer Agents
4小时前
待确认
Discovery and biological evaluation of potent 2-trifluoromethyl acrylamide warhead-containing inhibitors of protein disulfide isomerase
2个月前
已关闭
Selective TYK2 inhibitors as potential therapeutic agents: a patent review (2019–2021)
2个月前
已完结
Discovery of IDOR-1117-1680, a dual orexin receptor antagonist with fast onset and short duration of action for the treatment of insomnia
3个月前
已完结
Elinzanetant for the Treatment of Vasomotor Symptoms Associated With Menopause
3个月前
已完结
Efficacy and safety of fezolinetant and elinzanetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis
3个月前
已完结
Discovery of LHQ490 as a highly selective fibroblast growth factor receptor 2 (FGFR2) inhibitor
4个月前
已完结
Pradefovir: A Prodrug That Targets Adefovir to the Liver for the Treatment of Hepatitis B
5个月前
已关闭
Recent Progress and Future Perspectives on Anti-Hyperuricemic Agents
5个月前
已完结
Discovery of WRN inhibitor HRO761 with synthetic lethality in MSI cancers
6个月前
已完结
皖公网安备34019202002308
